RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. WuXi Biologics
W

WuXi Biologics portfolio

WuXi Biologics has 1 portfolio company on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $73M.
Latest deal: Immune-Onc Therapeutics · Mar 30, 2021.
About this page

Its most recent investment on record is Immune-Onc Therapeutics's $73M Series B+ round in March 2021, alongside Yanchuang Capital, Tao Capital, Octagon Capital Advisors and 6 others. That company is in Health and bio.

What WuXi Biologics invests in

How WuXi Biologics invests

StageDealsCapital in rounds
Series B+ 1 100%$73M

WuXi Biologics portfolio companies

CompanyRound with WuXi BiologicsTotal raisedLatest raise
IImmune-Onc Therapeutics
Health and bio
Series B+ · $73M$211MJan 5, 2023
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name WuXi Biologics. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists WuXi Biologics, which is a subset of its real portfolio. API: /api/v1/investors/wuxi-biologics (get a free API key). More: the most active VC firms and new venture capital funds.